Crucially Jonhson and Johnson and Astra Zenica are to report preliminary findings on the effect the south african strain are having on their vaccines shorthly. This is very important.
Lab studies in the last week have been mixed to disturbing. But the negativity around them will melt away if we find the variant doesnt significantly increase severe illness in respect to those vaccines.
The lab studies show the new strain has a few tricks up its sleeve in regard our best drugs and antibody protection provided by previous infection of the original virus. Potentially 1 out of every 2 patients not being provided with protection. This would dismiss the idea of natural herd immunity on a medium timescale if the effect translated to real world. There is alot of uncertainty in what these lab studies really show but they certainly don't show the vaccine doesnt't work. Thats far more complicated.
Leaked footage of the british health secreatry Hancock suggesting a 50% reduction in vaccine efficacy may just be poliical noise or his misunderstanding of the significance of the lab studies that came out the previous week. Or he may be privy to something not released. I hope not.
The UK variant may have a 30-40% higher mortality rate but they arent sure. It takes a sample size of tens of thousands of deaths over an extended period to try to detect a signal like that. The brits have the only real world sample that could show it. Counter-intuitively a higher transmission rate is far worse than an equivalent higher mortality rate as a less deadly virus makes up with fewer deaths by sheer volume of infections.
Its worth noting that the more transmissive variant always become the dominant variant. It does this if the virus is increasing, decreasing or stable in the population. In either of the 3 scenarios it doubles each week relative to the less transmissive variant if it about 50% more transmissive. It doesnt need to double in absolute numbers, just double against its less transmissive sibling.
if its at 1% it goes to 2, then 4, then 8, then 16, then 32 then over half in 5 to 6 weeks. Its probably a bit of a lottery how long it takes to get to 0.5% and then fairly predictable there after. The march from zero to 0.5% would take far longer then the march from stage of 0.5% to 50%. This means there is probably a disportionate value in trying to prevent or slow the south african strain than trying to slow the uk strain in continental europe and north america.
Lab studies in the last week have been mixed to disturbing. But the negativity around them will melt away if we find the variant doesnt significantly increase severe illness in respect to those vaccines.
The lab studies show the new strain has a few tricks up its sleeve in regard our best drugs and antibody protection provided by previous infection of the original virus. Potentially 1 out of every 2 patients not being provided with protection. This would dismiss the idea of natural herd immunity on a medium timescale if the effect translated to real world. There is alot of uncertainty in what these lab studies really show but they certainly don't show the vaccine doesnt't work. Thats far more complicated.
Leaked footage of the british health secreatry Hancock suggesting a 50% reduction in vaccine efficacy may just be poliical noise or his misunderstanding of the significance of the lab studies that came out the previous week. Or he may be privy to something not released. I hope not.
The UK variant may have a 30-40% higher mortality rate but they arent sure. It takes a sample size of tens of thousands of deaths over an extended period to try to detect a signal like that. The brits have the only real world sample that could show it. Counter-intuitively a higher transmission rate is far worse than an equivalent higher mortality rate as a less deadly virus makes up with fewer deaths by sheer volume of infections.
Its worth noting that the more transmissive variant always become the dominant variant. It does this if the virus is increasing, decreasing or stable in the population. In either of the 3 scenarios it doubles each week relative to the less transmissive variant if it about 50% more transmissive. It doesnt need to double in absolute numbers, just double against its less transmissive sibling.
if its at 1% it goes to 2, then 4, then 8, then 16, then 32 then over half in 5 to 6 weeks. Its probably a bit of a lottery how long it takes to get to 0.5% and then fairly predictable there after. The march from zero to 0.5% would take far longer then the march from stage of 0.5% to 50%. This means there is probably a disportionate value in trying to prevent or slow the south african strain than trying to slow the uk strain in continental europe and north america.
Comment